Lung Screen Uptake Trial: results from a single lung cancer screening round

Thorax. 2020 Oct;75(10):908-912. doi: 10.1136/thoraxjnl-2020-214703. Epub 2020 Aug 5.

Abstract

The Lung Screen Uptake Trial tested a novel invitation strategy to improve uptake and reduce socioeconomic and smoking-related inequalities in lung cancer screening (LCS) participation. It provides one of the first UK-based 'real-world' LCS cohorts. Of 2012 invited, 1058 (52.6%) attended a 'lung health check'. 768/996 (77.1%) in the present analysis underwent a low-dose CT scan. 92 (11.9%) and 33 (4.3%) participants had indeterminate pulmonary nodules requiring 3-month and 12-month surveillance, respectively; 36 lung cancers (4.7%) were diagnosed (median follow-up: 1044 days). 72.2% of lung cancers were stage I/II and 79.4% of non-small cell lung cancer had curative-intent treatment.

Keywords: imaging/CT MRI etc; lung cancer.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Carcinoma / diagnosis*
  • Cohort Studies
  • Early Detection of Cancer*
  • Female
  • Humans
  • Lung Neoplasms / diagnosis*
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Patient Acceptance of Health Care*
  • Radiation Dosage
  • Socioeconomic Factors
  • United Kingdom